Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Oncology Based Molecular Diagnostic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oncology Based Molecular Diagnostic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oncology Based Molecular Diagnostic Overall Market Size
2.1 Global Oncology Based Molecular Diagnostic Market Size: 2022 VS 2029
2.2 Global Oncology Based Molecular Diagnostic Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Oncology Based Molecular Diagnostic Players in Global Market
3.2 Top Global Oncology Based Molecular Diagnostic Companies Ranked by Revenue
3.3 Global Oncology Based Molecular Diagnostic Revenue by Companies
3.4 Top 3 and Top 5 Oncology Based Molecular Diagnostic Companies in Global Market, by Revenue in 2022
3.5 Global Companies Oncology Based Molecular Diagnostic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oncology Based Molecular Diagnostic Players in Global Market
3.6.1 List of Global Tier 1 Oncology Based Molecular Diagnostic Companies
3.6.2 List of Global Tier 2 and Tier 3 Oncology Based Molecular Diagnostic Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Oncology Based Molecular Diagnostic Market Size Markets, 2022 & 2029
4.1.2 Instruments
4.1.3 Reagents
4.2 By Type - Global Oncology Based Molecular Diagnostic Revenue & Forecasts
4.2.1 By Type - Global Oncology Based Molecular Diagnostic Revenue, 2018-2023
4.2.2 By Type - Global Oncology Based Molecular Diagnostic Revenue, 2024-2029
4.2.3 By Type - Global Oncology Based Molecular Diagnostic Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Oncology Based Molecular Diagnostic Market Size, 2022 & 2029
5.1.2 Breast Cancer
5.1.3 Prostate Cancer
5.1.4 Colorectal Cancer
5.1.5 Cervical Cancer
5.1.6 Liver Cancer
5.1.7 Lung Cancer
5.1.8 Blood Cancer
5.1.9 Kidney Cancer
5.2 By Application - Global Oncology Based Molecular Diagnostic Revenue & Forecasts
5.2.1 By Application - Global Oncology Based Molecular Diagnostic Revenue, 2018-2023
5.2.2 By Application - Global Oncology Based Molecular Diagnostic Revenue, 2024-2029
5.2.3 By Application - Global Oncology Based Molecular Diagnostic Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Oncology Based Molecular Diagnostic Market Size, 2022 & 2029
6.2 By Region - Global Oncology Based Molecular Diagnostic Revenue & Forecasts
6.2.1 By Region - Global Oncology Based Molecular Diagnostic Revenue, 2018-2023
6.2.2 By Region - Global Oncology Based Molecular Diagnostic Revenue, 2024-2029
6.2.3 By Region - Global Oncology Based Molecular Diagnostic Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Oncology Based Molecular Diagnostic Revenue, 2018-2029
6.3.2 US Oncology Based Molecular Diagnostic Market Size, 2018-2029
6.3.3 Canada Oncology Based Molecular Diagnostic Market Size, 2018-2029
6.3.4 Mexico Oncology Based Molecular Diagnostic Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Oncology Based Molecular Diagnostic Revenue, 2018-2029
6.4.2 Germany Oncology Based Molecular Diagnostic Market Size, 2018-2029
6.4.3 France Oncology Based Molecular Diagnostic Market Size, 2018-2029
6.4.4 U.K. Oncology Based Molecular Diagnostic Market Size, 2018-2029
6.4.5 Italy Oncology Based Molecular Diagnostic Market Size, 2018-2029
6.4.6 Russia Oncology Based Molecular Diagnostic Market Size, 2018-2029
6.4.7 Nordic Countries Oncology Based Molecular Diagnostic Market Size, 2018-2029
6.4.8 Benelux Oncology Based Molecular Diagnostic Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Oncology Based Molecular Diagnostic Revenue, 2018-2029
6.5.2 China Oncology Based Molecular Diagnostic Market Size, 2018-2029
6.5.3 Japan Oncology Based Molecular Diagnostic Market Size, 2018-2029
6.5.4 South Korea Oncology Based Molecular Diagnostic Market Size, 2018-2029
6.5.5 Southeast Asia Oncology Based Molecular Diagnostic Market Size, 2018-2029
6.5.6 India Oncology Based Molecular Diagnostic Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Oncology Based Molecular Diagnostic Revenue, 2018-2029
6.6.2 Brazil Oncology Based Molecular Diagnostic Market Size, 2018-2029
6.6.3 Argentina Oncology Based Molecular Diagnostic Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Oncology Based Molecular Diagnostic Revenue, 2018-2029
6.7.2 Turkey Oncology Based Molecular Diagnostic Market Size, 2018-2029
6.7.3 Israel Oncology Based Molecular Diagnostic Market Size, 2018-2029
6.7.4 Saudi Arabia Oncology Based Molecular Diagnostic Market Size, 2018-2029
6.7.5 UAE Oncology Based Molecular Diagnostic Market Size, 2018-2029
7 Oncology Based Molecular Diagnostic Companies Profiles
7.1 Abbott
7.1.1 Abbott Company Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Oncology Based Molecular Diagnostic Major Product Offerings
7.1.4 Abbott Oncology Based Molecular Diagnostic Revenue in Global Market (2018-2023)
7.1.5 Abbott Key News & Latest Developments
7.2 Bayer Healthcare
7.2.1 Bayer Healthcare Company Summary
7.2.2 Bayer Healthcare Business Overview
7.2.3 Bayer Healthcare Oncology Based Molecular Diagnostic Major Product Offerings
7.2.4 Bayer Healthcare Oncology Based Molecular Diagnostic Revenue in Global Market (2018-2023)
7.2.5 Bayer Healthcare Key News & Latest Developments
7.3 Beckton Dickinson
7.3.1 Beckton Dickinson Company Summary
7.3.2 Beckton Dickinson Business Overview
7.3.3 Beckton Dickinson Oncology Based Molecular Diagnostic Major Product Offerings
7.3.4 Beckton Dickinson Oncology Based Molecular Diagnostic Revenue in Global Market (2018-2023)
7.3.5 Beckton Dickinson Key News & Latest Developments
7.4 Cepheid
7.4.1 Cepheid Company Summary
7.4.2 Cepheid Business Overview
7.4.3 Cepheid Oncology Based Molecular Diagnostic Major Product Offerings
7.4.4 Cepheid Oncology Based Molecular Diagnostic Revenue in Global Market (2018-2023)
7.4.5 Cepheid Key News & Latest Developments
7.5 Dako
7.5.1 Dako Company Summary
7.5.2 Dako Business Overview
7.5.3 Dako Oncology Based Molecular Diagnostic Major Product Offerings
7.5.4 Dako Oncology Based Molecular Diagnostic Revenue in Global Market (2018-2023)
7.5.5 Dako Key News & Latest Developments
7.6 Hologic
7.6.1 Hologic Company Summary
7.6.2 Hologic Business Overview
7.6.3 Hologic Oncology Based Molecular Diagnostic Major Product Offerings
7.6.4 Hologic Oncology Based Molecular Diagnostic Revenue in Global Market (2018-2023)
7.6.5 Hologic Key News & Latest Developments
7.7 Qiagen
7.7.1 Qiagen Company Summary
7.7.2 Qiagen Business Overview
7.7.3 Qiagen Oncology Based Molecular Diagnostic Major Product Offerings
7.7.4 Qiagen Oncology Based Molecular Diagnostic Revenue in Global Market (2018-2023)
7.7.5 Qiagen Key News & Latest Developments
7.8 Roche
7.8.1 Roche Company Summary
7.8.2 Roche Business Overview
7.8.3 Roche Oncology Based Molecular Diagnostic Major Product Offerings
7.8.4 Roche Oncology Based Molecular Diagnostic Revenue in Global Market (2018-2023)
7.8.5 Roche Key News & Latest Developments
7.9 Siemens Healthineers
7.9.1 Siemens Healthineers Company Summary
7.9.2 Siemens Healthineers Business Overview
7.9.3 Siemens Healthineers Oncology Based Molecular Diagnostic Major Product Offerings
7.9.4 Siemens Healthineers Oncology Based Molecular Diagnostic Revenue in Global Market (2018-2023)
7.9.5 Siemens Healthineers Key News & Latest Developments
7.10 Sysmex
7.10.1 Sysmex Company Summary
7.10.2 Sysmex Business Overview
7.10.3 Sysmex Oncology Based Molecular Diagnostic Major Product Offerings
7.10.4 Sysmex Oncology Based Molecular Diagnostic Revenue in Global Market (2018-2023)
7.10.5 Sysmex Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer